title: [Evaluation of neo-adjuvant therapy (NAT) applied to clinical stage III of lung cancer at our center].
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: I
authors.initials: I
authors.lastname: Mikami
authors.forename: H
authors.initials: H
authors.lastname: Nishimura
authors.forename: H
authors.initials: H
authors.lastname: Akiyama
authors.forename: Y
authors.initials: Y
authors.lastname: Mazaki
authors.forename: H
authors.initials: H
authors.lastname: Haraguchi
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000628:therapy; D018287:Carcinoma, Large Cell / Q000401:mortality / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate